skip to main content
Refinado por: Nome da Publicação: Journal For Immunotherapy Of Cancer remover assunto: Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response
Material Type:
Artigo
Adicionar ao Meu Espaço

Nivolumab in chemotherapy-resistant cervical cancer: report of a vulvitis as a novel immune-related adverse event and molecular analysis of a persistent complete response

Baettig, Florence ; Vlajnic, Tatjana ; Vetter, Marcus ; Glatz, Katharina ; Hench, Jürgen ; Frank, Stephan ; Bihl, Michel ; Lopez, Roberto ; Dobbie, Michael ; Heinzelmann-Schwarz, Viola ; Montavon, Céline

Journal for immunotherapy of cancer, 2019-10, Vol.7 (1), p.281-281, Article 281 [Periódico revisado por pares]

England: BMJ Publishing Group Ltd

Texto completo disponível

2
Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 + T cells in the tumor microenvironment
Material Type:
Artigo
Adicionar ao Meu Espaço

Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 + T cells in the tumor microenvironment

Tada, Yasuko ; Togashi, Yosuke ; Kotani, Daisuke ; Kuwata, Takeshi ; Sato, Eichi ; Kawazoe, Akihito ; Doi, Toshihiko ; Wada, Hisashi ; Nishikawa, Hiroyoshi ; Shitara, Kohei

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.106-106, Article 106 [Periódico revisado por pares]

England: BioMed Central Ltd

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.